Drug discovery data management solutions and services. Share compounds and biological data, generate ad-hoc reports for decision-making. Integrate your own results with publicly available information. Virtual screening in large compound librairies, create QSAR models for lead optimization. Create and validate biomarker panels using the latest bioinformatics algorithms. Align sequences, sort by region, highlight mutations, automatically align onto a list of potential scaffolds.

A joint organization of EIP and the ABIRISK team. Acts as a central meeting place for European biopharmaceutical companies and scientific experts active in the field of immunogenicity. Interaction with authorities regarding immunogenicity guidelines. Formulate active recommendations regarding immunogenicity. Stimulate research addressing the clinical and non-clinical effects of unwanted immunogenicity.

We are keen to assist European biotech professionals as they are exploring the Boston and will organize frequent meetings with European visitors. Friday, August 11, 2006. A new way to go public, EUROPE! Loking for money, but to small to target the NASDAQ. A Bay Area Biotech, Napo Pharmaceuticals Inc.

Do the best you can until you know better. When you know better, do better. 7th Annual Trivia Night and Silent Auction. American Red Cross Blood Drive. Subscribe to our email newsletter and receive updates and the latest news. Matthew And Andrew Akin Foundation.

Rosetta Capital is a specialist venture capital firm focused in the life science and medical technology sectors. Rosetta is headquartered in the United Kingdom and manages funds comprising more than 30 active portfolio companies across Europe, North America and Asia. Consilium Strategic Communications features Rosetta article on. Investing in the Life Science Secondary Market. Paratek Pharmaceuticals Completes Merger With Transcept Pharmaceuticals.